News | News By Subject | News by Disease News By Date | Search News

Osteoarthritis News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Regeneron (REGN)'s Pain Drug Fasinumab Meets Goals in Late Stage Study     5/2/2016
After Mixed Clinical Trial Results, Bay Area’s Carbylan Engages Wedbush PacGrow to Evaluate Options     3/18/2016
Flexion (FLXN) Rockets as Lead Drug Meets Primary Endpoint in Late Stage Study     2/18/2016
Gilead (GILD) May Take Page Out of Pfizer (PFE)'s Game Plan as Firm Hunts for M&As to Sustain Growth     2/4/2016
Carbylan Therapeutics Ostearthrtis Drug Gets Half the Job Done in Late-Stage Study     2/2/2016
Up or Down, Three Biotechs that Will Face Major Decisions Soon     1/19/2016
Zosano (ZSAN) Terminates Eli Lilly (LLY) Deal, Halts Daily Osteoporosis Drug Program     9/29/2015
Flexion (FLXN) Tanks as Lead Drug Flunks Pivotal Phase IIb Clinical Trial     9/10/2015
Silicon Valley Biotech Carbylan Therapeutics Files for $86 Million     1/2/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Ampio Pharmaceuticals, Inc. (AMPE) Could Have A Blockbuster Fourth Quarter, Says Citi     10/29/2014
Flexion Therapeutics (FLXN) Reports FDA Clinical Hold For Phase 2b Trial Of Osteoarthritis Drug     9/19/2014
Wall Street Shouldn't Write Off Ampio Pharmaceuticals, Inc. (AMPE) Yet: Citi Analysts     9/16/2014
Ampio Pharmaceuticals, Inc. (AMPE) Touts Very Positive Data For Ampion Osteoarthrtis Study     8/18/2014

News from Around the Web
Body Clocks Linked to Osteoarthritis, University of Manchester Study     6/12/2013
Protein May Alter Inevitability of Osteoarthritis, Howard Hughes Medical Institute Study     3/14/2013
Uric Acid May Increase Likelihood of Severe Osteoarthritis, Duke University Study     1/18/2011
Study Shows Garlic Could Protect Against Hip Osteoarthritis, King's College London and University of East Anglia Study     12/17/2010
Tanezumab Helps Osteoarthritis, But Trials Stopped, University of California, Davis (UCD) Study     9/30/2010
Sham Acupuncture Matches the Real Thing in Knee OA, University of Texas MD Anderson Cancer Center Study Published in Arthritis Care & Research     8/18/2010
Lubricating The Knee Cartilage After ACL Injury May Prevent Osteoarthritis, Brown University Study     8/6/2010
Surgery for Injured Knees Fails to Stave Off Arthritis, Leiden University Medical Center Study     6/30/2010
Duke University Study Suggests Obesity Alone Does Not Cause Knee Osteoarthritis     9/29/2009
Hormone Promises To Keep Joint Injuries From Causing Long-term Osteoarthritis, University of Rochester Medical Center Study     9/14/2009
Ethnic Differences In Arthritis Due To Obesity, University of Arizona Study     10/20/2008
Chondroitin Sulphate Linked To Lower Knee Swelling, Scientists At University of Utah School of Medicine And University of Maryland School of Medicine Say     10/6/2008
Dietary Supplements Glucosamine and/or Chondroitin Fare No Better than Placebo in Slowing Structural Damage of Knee Osteoarthritis, University of Utah School of Medicine and National Institutes of Health (NIH) Study     9/30/2008
Popular Surgery Provides No Relief For Osteoarthritis Of The Knee, University of Western Ontario and Lawson Health Research Institute Study Finds     9/11/2008
Pomegranate Extract Shows Joint Health Potential, Case Western Reserve University Study     6/6/2008

Press Releases
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Statistically Significant Efficacy In A Highly Translational Preclinical Model Of Chronic Osteoarthritis Pain     1/9/2017
Bioiberica Release: New Study Finds Chondroitin Sulfate Superior To Celecoxib For Delaying The Progression Of Knee Osteoarthritis     1/9/2017
TLC Biopharmaceuticals, Inc. Reports Results Of Phase 1/2 Clinical Trial Of TLC599 For Sustained Pain Relief In The Treatment Of Osteoarthritis Of The Knee     1/6/2017
Iroko Pharma Announces Key Patent For VIVLODEX     1/6/2017
OrthoTrophix Release: Significant Improvements In Knee Function After TPX-100 Administration In A Double-Blind, Placebo-Controlled Phase 2 Study Of Knee Osteoarthritis     12/16/2016
Centrexion Touts Success of Phase IIb Study for Knee Osteoarthritis Pain     12/13/2016
Centrexion Announces Highly Statistically Significant Topline Results From Phase 2b Study Of CNTX-4975 In Patients With Knee Osteoarthritis Pain     12/13/2016
Sun Pharma (SUNPHARMA.NS) & Moebius Medical Sign Exclusive Global Licensing Deal To Develop Novel Liposomal Non-Opioid Pain Product For Osteoarthritis     12/12/2016
Medivir (MVRBF) Release: MIV-711 Osteoarthritis Trial: Successful Third Independent Review Of Safety Data And Trial Continues Without Any Modifications     12/8/2016
Samumed’s Wnt Pathway Modulator SM04690 Shows Potential As A Disease Modifying Treatment For Osteoarthritis (OA) Of The Knee     11/15/2016
Samumed Presents Data For A Small Molecule Modulator Of Wnt Pathway As A Potential Topical Treatment For Chronic Tendinopathy     11/14/2016
Bioventus Expands To Mexico With DUROLANE For Knee Osteoarthritis Patients     11/14/2016
Symic Biomedical And Nordic Bioscience A/S Complete Enrollment Of MODIFY-OA Trial Of SB-061 For The Treatment Of Osteoarthritis     11/11/2016
Atrium Innovations Release: New Research Highlights Efficacy Of Oral Enzyme Combination Over NSAID In Treatment Of Osteoarthritis     11/8/2016
Flexion (FLXN) Reports Primary Endpoint Met In Clinical Trial Evaluating Investigational Drug Candidate Zilretta In Type 2 Diabetes Patients With Knee Osteoarthritis     11/2/2016

//-->